Purchase Order HHSN272201400852P
Award Date
8/11/14
Potential Completion Date
8/31/15
Potential Value
$100K
Federal Agency
NIAID DEA OA Acquisitions
Awardee
Maxcyte, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Maxcyte, Inc. was awarded a firm fixed price purchase order totaling $475,000 by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for a one year lease of one Maxcyte GT Flow Transfection System including licensing, software, on-site upgrade, maintenance, training of NIH staff, and service. Performance will take place in Potomac, Maryland. No set-aside was used for this award. As the prime contractor,...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order contract to Maxcyte, Inc., a small business, for the procurement of a MaxCyte ATX Scalable Transfection System with software licenses. The contract has a potential value of $50,069.70 and was awarded on March 18, 2019 with a completion date of June 2, 2019. The award was made on a sole-source basis under the...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $49,710 purchase order to Maxcyte, Inc. of Potomac, Maryland under a firm fixed price contract. The contract is for the delivery of a Maxcyte E-ATX Cell Processor to support the NIH/NIAID's research efforts through September 15, 2023. As the prime contractor, Maxcyte will provide its cell processing equipment without support from major subcontractors. The...
This is a federal contract award by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Maxcyte, Inc. for a Transfection System. The contract has a firm fixed price of $81,385.00 and was awarded on August 8, 2018 with a completion date of September 7, 2018. The award was made without a set-aside. Maxcyte, Inc. is a commercial cell engineering company that has previously provided specialized laboratory equipment...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Maxcyte, Inc. The contract is for the provision of an EXPERT STX SCALABLE TRANSFECTION SYSTEM, a specialized laboratory technology, to support the agency's biomedical research mission. The contract has a ceiling value of $107,300.00 and a period of performance through September 20, 2024. Maxcyte, Inc. is a...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Maxcyte, Inc., a commercial cell engineering company. The $24,200.00 contract is for the provision of MAXCYTE PROCESSING ASSEMBLIES. Maxcyte has previously held prime federal contracts with agencies like NIH, the Food and Drug Administration, and Department of Veterans Affairs to deliver specialized...
The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $59,500 purchase order to Maxcyte, Inc. to acquire a MaxCyte ATX Scalable Transfection System, along with processing assemblies and software licenses. The non-competitive award was justified as Maxcyte's proprietary electroporation technology is necessary to allow for the manipulation of transcription factor protein expression. The purchase...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Maxcyte, Inc., a leading commercial cell engineering company, for the delivery of a PROCESSING ASSEMBLY, CL-1.1 3.5-ML (REAGENTS). The firm fixed price contract, with a potential value of $12,130.00, has an award date of February 15, 2019 and a completion date of April 19, 2019. There was no set-aside used for this contract...
The National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, awarded a $55,200.00 firm fixed price purchase order to Maxcyte, Inc., a for-profit corporate entity based in Rockville, Maryland. The contract is for the procurement of an EXPERT ATX Electroporation Platform, Generation 3 with accessories, to be used for developing gene editing tools for in vivo gene therapy research. This specialized laboratory equipment supports the agency's...
This is a $120,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), a civilian federal agency. The contract was awarded to Maxcyte, Inc., a commercial cell engineering company, to provide specialized laboratory equipment and technologies such as cell processing systems, electroporation and scalable transfection systems, and related consumables and maintenance services to support NIDA's...